cyclic-gmp has been researched along with ezogabine* in 1 studies
1 other study(ies) available for cyclic-gmp and ezogabine
Article | Year |
---|---|
egl-4 modulates electroconvulsive seizure duration in C. elegans.
Increased neuronal excitability causes seizures with debilitating symptoms. Effective and noninvasive treatments are limited for easing symptoms, partially due to the complexity of the disorder and lack of knowledge of specific molecular faults. An unexplored, novel target for seizure therapeutics is the cGMP/protein kinase G (PKG) pathway, which targets downstream K Topics: Animals; Anticonvulsants; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Carbamates; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Electroshock; Phenylenediamines; Recovery of Function; Seizures; Signal Transduction | 2018 |